Comparative efficacy of combination immunotherapy and targeted therapy in the treatment of BRAF-mutant advanced melanoma: a matching-adjusted indirect comparison

Braf Mutant

A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma☆

ESMO Open ◽

10.1016/j.esmoop.2021.100050 ◽

2021 ◽

Vol 6 (2) ◽

pp. 100050

Author(s):

A.A. Tarhini ◽

K. Toor ◽

K. Chan ◽

D.F. McDermott ◽

P. Mohr ◽

...

Keyword(s):

Indirect Comparison ◽

Advanced Melanoma ◽

Mek Inhibitors ◽

Braf Mutant

Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison

Advances in Therapy ◽

10.1007/s12325-021-01700-2 ◽

2021 ◽

Author(s):

Jörg Trojan ◽

Patrick Mollon ◽

Bruno Daniele ◽

Florence Marteau ◽

Lidia Martín ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Indirect Comparison ◽

Alpha Fetoprotein ◽

Comparative Efficacy ◽

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

CNS Drugs ◽

10.1007/s40263-013-0102-x ◽

2013 ◽

Vol 27 (11) ◽

pp. 943-953 ◽

Cited By ~ 21

Author(s):

Vanja Sikirica ◽

Robert L. Findling ◽

James Signorovitch ◽

M. Haim Erder ◽

Ryan Dammerman ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Indirect Comparison ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

PND9 Comparative Efficacy and Safety of Ozanimod Versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Matching-Adjusted Indirect Comparison

Value in Health ◽

10.1016/j.jval.2020.08.1334 ◽

2020 ◽

Vol 23 ◽

pp. S624

Author(s):

S. Cohan ◽

J. Kumar ◽

S. Arndorfer ◽

X. Zhu ◽

M. Zivkovic ◽

...

Keyword(s):

Multiple Sclerosis ◽

Indirect Comparison ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis

Remitting Multiple Sclerosis ◽

Comparative efficacy of ceritinib and crizotinib in previously treated crizotinib-naïve anaplastic lymphoma kinase-positive (ALK+) advanced or metastatic non-small cell lung cancer (NSCLC): An adjusted indirect comparison.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8058 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8058-8058

Author(s):

Daniel Shao-Weng Tan ◽

Antonio Araujo ◽

Jie Zhang ◽

James E. Signorovitch ◽

Zheng-Yi Zhou ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Indirect Comparison ◽

Small Cell ◽

Comparative Efficacy ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Previously Treated

Comparative efficacy of first-line ceritinib and crizotinib in advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer: an adjusted indirect comparison with external controls

Current Medical Research and Opinion ◽

10.1080/03007995.2018.1541443 ◽

2018 ◽

Vol 35 (1) ◽

pp. 105-111 ◽

Cited By ~ 3

Author(s):

Junlong Li ◽

Stefanie Knoll ◽

Iryna Bocharova ◽

Wenxi Tang ◽

James Signorovitch

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Indirect Comparison ◽

Small Cell ◽

Comparative Efficacy ◽

Small Cell Lung ◽

First Line ◽

Anaplastic Lymphoma ◽

Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison

Advances in Therapy ◽

10.1007/s12325-020-01599-1 ◽

2020 ◽

Author(s):

Zalmai Hakimi ◽

Elena Santagostino ◽

Maarten J. Postma ◽

Jameel Nazir

Keyword(s):

Indirect Comparison ◽

Haemophilia A ◽

Comparative Efficacy ◽

Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low Dose Dexamethasone (POMA+LODEX) in The Treatment of Multiple Myeloma : A Matching Adjusted Indirect Comparison (MAIC)

Value in Health ◽

10.1016/j.jval.2016.09.2103 ◽

2016 ◽

Vol 19 (7) ◽

pp. A713-A714 ◽

Cited By ~ 1

Author(s):

S van Sanden ◽

T Ito ◽

M Vogel ◽

J Diels

Keyword(s):

Multiple Myeloma ◽

Low Dose ◽

Indirect Comparison ◽

Comparative Efficacy ◽

P0866 : Comparative efficacy and tolerability of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for hepatitis C genotype 3: A matching-adjusted indirect comparison

Journal of Hepatology ◽

10.1016/s0168-8278(15)31068-0 ◽

2015 ◽

Vol 62 ◽

pp. S665 ◽

Cited By ~ 1

Author(s):

E. Swallow ◽

J. Song ◽

Y. Yuan ◽

A. Kalsekar ◽

C. Kelley ◽

...

Keyword(s):

Hepatitis C ◽

Indirect Comparison ◽

Comparative Efficacy ◽

Genotype 3 ◽

PND7 Assessing the Comparative Efficacy of INP104 for Acute Treatment of Migraine Attacks: A Matching-Adjusted Indirect Comparison

Value in Health ◽

10.1016/j.jval.2021.04.791 ◽

2021 ◽

Vol 24 ◽

pp. S159

Author(s):

S. Joshi ◽

S.K. Aurora ◽

S. Wang ◽

J.E. Park ◽

P. Wu ◽

...

Keyword(s):

Acute Treatment ◽

Indirect Comparison ◽

Comparative Efficacy ◽